908 Devices (NASDAQ:MASS) Earns "Sell (E+)" Rating from Weiss Ratings

908 Devices (NASDAQ:MASS - Get Free Report)'s stock had its "sell (e+)" rating reiterated by Weiss Ratings in a research note issued on Saturday,Weiss Ratings reports.

A number of other research firms also recently weighed in on MASS. Stifel Nicolaus decreased their price target on shares of 908 Devices from $17.00 to $6.00 and set a "buy" rating for the company in a research note on Wednesday, November 13th. Stephens reissued an "overweight" rating and set a $6.00 price objective on shares of 908 Devices in a report on Wednesday. Leerink Partners restated a "market perform" rating and issued a $4.00 target price (down from $12.00) on shares of 908 Devices in a research note on Wednesday, November 13th. Finally, Leerink Partnrs cut 908 Devices from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, November 13th. Two equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $5.33.

908 Devices Stock Performance

Shares of 908 Devices stock traded up $0.08 during mid-day trading on Friday, hitting $2.98. 1,347,475 shares of the stock were exchanged, compared to its average volume of 369,045. The company has a 50-day simple moving average of $2.36 and a 200 day simple moving average of $3.50. 908 Devices has a 12 month low of $1.81 and a 12 month high of $8.50. The company has a market capitalization of $103.76 million, a P/E ratio of -1.68 and a beta of 0.96.

Institutional Trading of 908 Devices

Institutional investors and hedge funds have recently modified their holdings of the business. SG Americas Securities LLC purchased a new stake in 908 Devices in the third quarter valued at approximately $36,000. B. Riley Wealth Advisors Inc. purchased a new stake in shares of 908 Devices during the 3rd quarter valued at $45,000. Drive Wealth Management LLC bought a new stake in shares of 908 Devices during the 3rd quarter worth $50,000. Townsquare Capital LLC purchased a new position in 908 Devices in the third quarter worth $50,000. Finally, 49 Wealth Management LLC increased its stake in 908 Devices by 16.2% in the third quarter. 49 Wealth Management LLC now owns 31,099 shares of the company's stock valued at $108,000 after acquiring an additional 4,343 shares during the last quarter. Hedge funds and other institutional investors own 88.06% of the company's stock.

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.